|
Youquan Zou, Director of the Department of Pharmaceutical Sciences, Professor, Doctoral Supervisor
Wuhan University , Medical School
Area of Focus
Biomaterials | Biocompatibility | Tissue Engineering | Drug Delivery | Regenerative Medicine | Catalysis | Synthesis | Enzymatic | Green Chemistry | Sustainable | Pharmacology | Drug Design | Therapeutics | Bioactive Compounds | Chemical Synthesis |
|
Shuang Luo, Doctoral Supervisor
University of Chinese Academy of Sciences , Medical School
Area of Focus
Drug Chemistry | Organic Synthesis | Catalysis | Palladium | Asymmetric Reactions | Cyclization | Heterocycles | Carbonylation | Imidoylation | Chiral Compounds |
|
Xiao Liang, Associate Researcher
University of Chinese Academy of Sciences , Medical School
Area of Focus
Natural Products | Synthesis | Chemistry | Organic Chemistry | Asymmetric Synthesis | Bioactive Compounds | Pharmaceutical Chemistry | Catalysis | Total Synthesis | Alkaloids |
|
Yang Weibo, Doctoral Supervisor
University of Chinese Academy of Sciences , Medical School
Area of Focus
Organometallic Chemistry | Medicinal Chemistry | Catalysis | Macrocycles | Drug Discovery | C-H Activation | Transition Metals | Synthesis | Inhibitors | Natural Products |
|
Xiangrui Jiang, Doctoral Supervisor
University of Chinese Academy of Sciences , Medical School
Area of Focus
Small Molecule | Structure-Activity Relationship | Natural Products | Modification | Drug Synthesis | Process Research | Pharmaceutical Chemistry | Bioorganic Chemistry | Medicinal Chemistry | Synthetic Methods |
|
Xiaowei Wu, Master's Supervisor
University of Chinese Academy of Sciences , Medical School
Area of Focus
Drug Chemistry | Organic Synthesis | Small Molecule Drugs | Antitumor | Antiviral | Synthesis Methodology | Pharmacological Activity | Covalent Inhibitors | Catalysis | Heterocycles |
|
Bing Zhou, Doctoral Supervisor
University of Chinese Academy of Sciences , Medical School
Area of Focus
Epigenetics | Drug Discovery | Innovative Drugs | Histone Modification | Gene Regulation | Cancer Therapy | Biomarkers | Pharmacology | Molecular Biology | Clinical Trials | Medicinal Chemistry | Drug Design | Synthesis | Pharmacokinetics | Pharmacodynamics | Bioorganic Chemistry | Chemical Biology | Structure-Activity Relationship | Lead Optimization | Drug Metabolism | C-H Activation | Catalysis | Organic Synthesis | Reaction Mechanisms | Transition Metals | Functionalization | Method Development | Green Chemistry | Synthetic Methods | Chemical Reactions |
|
Yu Zhou, Group Leader, Doctoral Supervisor
University of Chinese Academy of Sciences , Medical School
Area of Focus
Drug Design | Synthesis | Pharmacology | Medicinal Chemistry | Bioorganic Chemistry | Pharmaceuticals | Therapeutics | Chemical Biology | Organic Synthesis | Drug Discovery |
|
Nan Fajun, Doctoral Supervisor
University of Chinese Academy of Sciences , Medical School
Area of Focus
Drug Synthesis | Organic Chemistry | Pharmaceutical Chemistry | Chemical Synthesis | Medicinal Chemistry | Drug Development | Synthetic Methods | Chemical Reactions | Molecular Design | Bioorganic Chemistry |
|
Nurmemet Abdukirim, Associate Researcher
University of Chinese Academy of Sciences , Medical School
Area of Focus
Organic Synthesis | Catalysis | Polysaccharides | Hydrogenation | Dimethyl Maleate | Dimethyl Succinate | Ru/Al2O3 Catalysts | Adsorption-Precipitation | Biological Activity | Medicinal Resources |
